Randomized phase II trial of daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer
- Resource Type
- Article
- Source
- In
Cancer Treatment and Research Communications 2017 12:56-61 - Subject
- Language
- ISSN
- 2468-2942